These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16943390)

  • 1. Universal screening methods and applications of ThermoFluor.
    Cummings MD; Farnum MA; Nelen MI
    J Biomol Screen; 2006 Oct; 11(7):854-63. PubMed ID: 16943390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for ligands using a generic and high-throughput light-scattering-based assay.
    Senisterra GA; Markin E; Yamazaki K; Hui R; Vedadi M; Awrey DE
    J Biomol Screen; 2006 Dec; 11(8):940-8. PubMed ID: 17092916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and applications of a broad-coverage, TR-FRET-based kinase binding assay platform.
    Lebakken CS; Riddle SM; Singh U; Frazee WJ; Eliason HC; Gao Y; Reichling LJ; Marks BD; Vogel KW
    J Biomol Screen; 2009 Sep; 14(8):924-35. PubMed ID: 19564447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virtual screen for ligands of orphan G protein-coupled receptors.
    Bock JR; Gough DA
    J Chem Inf Model; 2005; 45(5):1402-14. PubMed ID: 16180917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a fluorescent-tagged kinase assay system for the detection and characterization of allosteric kinase inhibitors.
    Simard JR; Getlik M; Grütter C; Pawar V; Wulfert S; Rabiller M; Rauh D
    J Am Chem Soc; 2009 Sep; 131(37):13286-96. PubMed ID: 19572644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative determination of protein stability and ligand binding using a green fluorescent protein reporter system.
    Moreau MJ; Morin I; Schaeffer PM
    Mol Biosyst; 2010 Jul; 6(7):1285-92. PubMed ID: 20454718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA-directed assembly microarray for protein and small molecule inhibitor screening.
    Kiat NJ; Simeon F; Phon TH; Ajikumar PK
    Methods Mol Biol; 2011; 716():127-40. PubMed ID: 21318903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery.
    Lo MC; Aulabaugh A; Jin G; Cowling R; Bard J; Malamas M; Ellestad G
    Anal Biochem; 2004 Sep; 332(1):153-9. PubMed ID: 15301960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-based high-throughput screening assay system for monitoring G protein-coupled receptor activation using beta-galactosidase enzyme complementation technology.
    Yan YX; Boldt-Houle DM; Tillotson BP; Gee MA; D'Eon BJ; Chang XJ; Olesen CE; Palmer MA
    J Biomol Screen; 2002 Oct; 7(5):451-9. PubMed ID: 14599361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Affinity selection-mass spectrometry screening techniques for small molecule drug discovery.
    Annis DA; Nickbarg E; Yang X; Ziebell MR; Whitehurst CE
    Curr Opin Chem Biol; 2007 Oct; 11(5):518-26. PubMed ID: 17931956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-throughput virtual screening of proteins using GRID molecular interaction fields.
    Sciabola S; Stanton RV; Mills JE; Flocco MM; Baroni M; Cruciani G; Perruccio F; Mason JS
    J Chem Inf Model; 2010 Jan; 50(1):155-69. PubMed ID: 19919042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence-derived three-dimensional pharmacophore models for G-protein-coupled receptors and their application in virtual screening.
    Klabunde T; Giegerich C; Evers A
    J Med Chem; 2009 May; 52(9):2923-32. PubMed ID: 19374402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ranking targets in structure-based virtual screening of three-dimensional protein libraries: methods and problems.
    Kellenberger E; Foata N; Rognan D
    J Chem Inf Model; 2008 May; 48(5):1014-25. PubMed ID: 18412328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Making drugs on proteins: site-directed ligand discovery for fragment-based lead assembly.
    Erlanson DA; Hansen SK
    Curr Opin Chem Biol; 2004 Aug; 8(4):399-406. PubMed ID: 15288250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orphan G-protein-coupled receptors: the next generation of drug targets?
    Wilson S; Bergsma DJ; Chambers JK; Muir AI; Fantom KG; Ellis C; Murdock PR; Herrity NC; Stadel JM
    Br J Pharmacol; 1998 Dec; 125(7):1387-92. PubMed ID: 9884064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scoring ligand similarity in structure-based virtual screening.
    Zavodszky MI; Rohatgi A; Van Voorst JR; Yan H; Kuhn LA
    J Mol Recognit; 2009; 22(4):280-92. PubMed ID: 19235177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of mass spectrometry technologies for the discovery of low-molecular weight modulators of enzymes and protein-protein interactions.
    Zehender H; Mayr LM
    Curr Opin Chem Biol; 2007 Oct; 11(5):511-7. PubMed ID: 17931957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virtual screening strategies in drug discovery.
    McInnes C
    Curr Opin Chem Biol; 2007 Oct; 11(5):494-502. PubMed ID: 17936059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.